United States · FDA National Drug Code directory

Hypothalmupar

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 44911-0473_e646941c-406d-4e3e-af16-bcd09d44ea78
Product NDC: 44911-0473
Form: LIQUID
Composition / generic term: Aralia Quinquefolia, Ginkgo Biloba, Hydrocotyle Asiatica, Cerebrum Suis, Hypophysis Suis, Hypothalamus Suis, Phosphorus, Silicea
Labeler: Energique, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20180924
Source listing expiry: 20261231

Source-listed ingredients

AMERICAN GINSENG — 3 [hp_X]/mL
GINKGO — 3 [hp_X]/mL
CENTELLA ASIATICA WHOLE — 3 [hp_X]/mL
SUS SCROFA CEREBRUM — 8 [hp_X]/mL
SUS SCROFA PITUITARY GLAND — 8 [hp_X]/mL
SUS SCROFA HYPOTHALAMUS — 12 [hp_X]/mL
PHOSPHORUS — 12 [hp_X]/mL
SILICON DIOXIDE — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

30 mL in 1 BOTTLE, DROPPER (44911-0473-1) · 44911-0473-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →